Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors

Ann Rheum Dis. 2022 Jul;81(7):e131. doi: 10.1136/annrheumdis-2020-218152. Epub 2020 Jun 25.
No abstract available

Keywords: antirheumatic agents; arthritis; autoimmune diseases; biological therapy; immune system diseases.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Biological Products* / therapeutic use
  • COVID-19*
  • Humans
  • Incidence
  • Janus Kinase Inhibitors* / therapeutic use
  • Rheumatic Diseases* / drug therapy
  • Rheumatic Diseases* / epidemiology

Substances

  • Antirheumatic Agents
  • Biological Products
  • Janus Kinase Inhibitors